- Home
- GTIM vs SABS Comparison
GTIM vs SABS Comparison
Compare GTIM & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTIM
- SABS
- Stock Information
- Founded
- GTIM 1987
- SABS 2014
- Country
- GTIM United States
- SABS United States
- Employees
- GTIM N/A
- SABS 63
- Industry
- GTIM Restaurants
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- GTIM Consumer Discretionary
- SABS Health Care
- Exchange
- GTIM Nasdaq
- SABS Nasdaq
- Market Cap
- GTIM 17.1M
- SABS 31.2M
- IPO Year
- GTIM 1990
- SABS N/A
- Fundamental
- Price
- GTIM $1.51
- SABS $2.98
- Analyst Decision
- GTIM
- SABS Strong Buy
- Analyst Count
- GTIM 0
- SABS 3
- Target Price
- GTIM N/A
- SABS $9.00
- AVG Volume (30 Days)
- GTIM 19.2K
- SABS 433.9K
- Earning Date
- GTIM 12-11-2025
- SABS 11-05-2025
- Dividend Yield
- GTIM N/A
- SABS N/A
- EPS Growth
- GTIM 17.03
- SABS N/A
- EPS
- GTIM 0.12
- SABS N/A
- Revenue
- GTIM $143,398,000.00
- SABS $114,698.00
- Revenue This Year
- GTIM N/A
- SABS N/A
- Revenue Next Year
- GTIM N/A
- SABS N/A
- P/E Ratio
- GTIM $12.89
- SABS N/A
- Revenue Growth
- GTIM 1.78
- SABS N/A
- 52 Week Low
- GTIM $1.24
- SABS $1.00
- 52 Week High
- GTIM $2.98
- SABS $6.60
- Technical
- Relative Strength Index (RSI)
- GTIM 40.92
- SABS 67.89
- Support Level
- GTIM $1.24
- SABS $2.10
- Resistance Level
- GTIM $1.58
- SABS $2.60
- Average True Range (ATR)
- GTIM 0.08
- SABS 0.24
- MACD
- GTIM -0.02
- SABS 0.08
- Stochastic Oscillator
- GTIM 59.09
- SABS 95.50
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.